Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5515b14e4fcdc67fa8a5273e37a804e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d5c56994aa6a8fa2e454e204c32d30e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd5c3f6f2775cb93b6426e09beedc6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d842b23b70ca2f4a253579fc9610f65 |
publicationDate |
2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2959021-A1 |
titleOfInvention |
Methods and kits for the molecular subtyping of tumors |
abstract |
The present invention relates to an in vitro method of identifying a molecular subtype of a tumor in a cancer patient and to a method of stratifying a cancer patient for tumor treatment. The present invention further relates to kits that are useful for identifying a molecular subtype of a tumor in a cancer patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11183286-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847253-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847252-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11264117-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10055540-B2 |
priorityDate |
2013-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |